Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. - Chonat S; Jones JA; Patel SR; Briones WM; Schoettler ML; Maarouf M; Jeffers LA; Adisa O; Tan F; Fields E; Sterling MS; Jajosky RP; et al. (Science translational medicine, 2025)